ロード中...
Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling
BACKGROUND: Bladder cancer (BLCA) is the fifth most common type of cancer worldwide, with high recurrence and progression rates. Although considerable progress has been made in the treatment of BLCA through accurate typing of molecular characteristics, little is known regarding the various genetic a...
保存先:
| 出版年: | Stem Cell Res Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7594303/ https://ncbi.nlm.nih.gov/pubmed/33115513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01973-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|